It looks like the FDA smackdown on 23andMe was only the beginning. Another personal genetics firm, GeneLink Biosciences, has been charged with false advertising by the Federal Trade Commission, on the grounds that the company didn’t have the requisite scientific grounds to market its services to consumers.